Craig B. Thompson: Featured News

Dr. Craig Thompson in his lab at the Sloan Kettering Institute
Mitochondria provide both the energy cells need to survive and the building blocks they need to grow and divide. Researchers at the Sloan Kettering Institute reveal for the first time how mitochondria choose between these opposing paths — and what implications it may have for cancer.
SKI cell biologists Junmei Yi and Xuejun Jiang
In the Lab
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
Macropinocytosis
New research from the Craig Thompson Lab offers a closer look at the transcriptional activators, Yap/Taz, and the role they play in cell growth and macropinocytosis.
Leukemia cells
Finding
A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.
T cells on the loose.
Feature
By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.
photo of sugary foods like candy, donuts, and cupcakes
Learn more about from MSK experts about what the latest research on the connection between eating sugar and cancer risk.
a circuit board
Feature
Scientists are dusting off their biochemistry textbooks in the hunt for clues to cancer.
Montage of beer, reproducing cells, and building blocks
Feature
MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.
IBM CEO Ginni Rometty Gets Past the Big Blues
President and CEO of Memorial Sloan Kettering Craig Thompson was interviewed about the collaboration between MSK and IBM Watson....
Assessing Research Productivity
President and CEO of Memorial Sloan Kettering Cancer Center Craig Thompson and colleagues discuss a new way of evaluating academic research....
A student asks a question at last year’s "Major Trends” seminar.
Event
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
MSK and Hartford leadership holding certificate
Announcement
The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Survivors and family members at our Manhattan event signed their names on a wall and wrote messages to staff and other patients.
Event
Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.
Memorial Sloan Kettering received a landmark gift of $100 million to undertake a unique and intensive endeavor to transform cancer care through genomic...
Pictured: 2014 Graduates
Event
Degrees were presented and awards were given at the 35th annual ceremony held on May 14.
Memorial Sloan Kettering President and CEO Craig Thompson was interviewed about the fundraising event Cycle for Survival that raises money for rare can...
Cancer research pioneer Janet Rowley
In Memoriam
Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.
Pictured: Michael Foley
Announcement
A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
Pictured: Craig Thompson
Event
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Donna Handley
Announcement
Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research.
Pictured: Barbara Raphael & Chioma Enweasor
Learning Curve
Our summer fellowship program helps medical students learn to become physician-scientists. Read about one of our trainees who investigated an imaging tool for use in patients with a rare uterine cancer.
A Conversation with Craig B. Thompson, MD
To mark the one-year anniversary of his tenure, President and CEO of Memorial Sloan Kettering Craig Thompson talked about recent discoveries and the ch...
Pictured: 2012 Rock Stars of Science
Announcement
The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.
Hundreds of high school students and teachers from the New York City area attend the annual seminar.
Event
For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
Pictured: Timothy Chan
In the Lab
Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.
Craig B. Thompson, MD
Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010.
Pictured: Craig Thompson
Perspective
Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Pictured: Craig Thompson
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Bottles filled with liquid
A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Three Memorial Sloan Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in <i>GQ</i> magazine's December "Men of the Year" issue.
DNA winding around histones
In the Lab
The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.